Soy isoflavones lower prostate cancer risk

March 14, 2007 in Cancer Prevention, Nutrition Topics in the News

Soy isoflavones lower prostate cancer risk

Researchers from Japan's National Cancer Centre report that increased intakes of soy isoflavones may lower prostate cancer risk by up to 50 percent.

Isoflavones are natural compounds that act as phytoestrogens in the body.  The major isoflavone in soy is genistein.

The study of more than 43,000 men with an average age of 57 reported their dietary intake using a food frequency questionnaire for five years.

The highest intake of soy isoflavones (32.8 milligrams of genistein per day) was associated with a 40 percent lower risk of localized prostate cancer compared to those with the lowest intake.

In men over 60, the protective effect was even stronger - the highest intakes of soy isoflavones were associated with a 50 percent lower risk.

All research on this web site is the property of Leslie Beck Nutrition Consulting Inc. and is protected by copyright. Keep in mind that research on these matters continues daily and is subject to change. The information presented is not intended as a substitute for medical treatment. It is intended to provide ongoing support of your healthy lifestyle practices.